Dolotranz and Pasireotide Extended-Release Injection
Determining the interaction of Dolotranz and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lidocaine / prilocaine topical
Brand name: Emla, Emla Anesthetic Disc, Livixil Pak, AgonEaze, Prizopak, LiproZonePak, Medolor Pak, Anodyne LPT
Synonyms: n.a.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolotranz-Pasireotide Injection
- Dolotranz-Pasireotide Subcutaneous
- Dolotranz-Patanase
- Dolotranz-Patiromer
- Dolotranz-Patiromer Sorbitex Calcium
- Dolotranz-Pavacot
- Pasireotide Extended-Release Injection-Dolutegravir
- Pasireotide Extended-Release Injection-Dolutegravir 10 mg
- Pasireotide Extended-Release Injection-Dolutegravir 25 mg and 50 mg
- Pasireotide Extended-Release Injection-Dolutegravir and lamivudine
- Pasireotide Extended-Release Injection-Dolutegravir and rilpivirine
- Pasireotide Extended-Release Injection-Dolutegravir Sodium